| Company Name: |
Shanghai Raise Chemical Technology Co.,Ltd
|
| Tel: |
15026594951 |
| Email: |
rs@raise-chem.com |
| Products Intro: |
Product Name:Isoquinoline, 1,2-dihydro-1-(1H-indol-3-yl)-2-[(phenylmethyl)sulfonyl]- CAS:313526-24-8 Purity:97% HPLC Package:1g;5g
|
Isoquinoline, 1,2-dihydro-1-(1H-indol-3-yl)-2-[(phenylmethyl)sulfonyl]- manufacturers
- IBR2
-
- $64.00
-
2026-06-02
- CAS:313526-24-8
- Purity: 99.50%
- Supply Ability: 10g
- IBR2
-
- $64.00
-
2026-06-02
- CAS:313526-24-8
- Purity: 99.50%
- Supply Ability: 10g
|
| | Isoquinoline, 1,2-dihydro-1-(1H-indol-3-yl)-2-[(phenylmethyl)sulfonyl]- Basic information |
| Product Name: | Isoquinoline, 1,2-dihydro-1-(1H-indol-3-yl)-2-[(phenylmethyl)sulfonyl]- | | Synonyms: | Isoquinoline, 1,2-dihydro-1-(1H-indol-3-yl)-2-[(phenylmethyl)sulfonyl]-;IBR2;IBR2
(IBR 2);2-(Benzylsulfonyl)-1-(1H-indol-3-yl)-1,2-dihydroisoquinoline;RAD51,Apoptosis,IBR-2,IBR2,inhibit,Inhibitor,IBR 2;2-(Benzylsulfonyl)-1-(1H-indol-3-yl)-1,2-dihydroisoquinoline , IBR2;IBR2, 10 mM in DMSO | | CAS: | 313526-24-8 | | MF: | C24H20N2O2S | | MW: | 400.49 | | EINECS: | | | Product Categories: | | | Mol File: | 313526-24-8.mol | ![Isoquinoline, 1,2-dihydro-1-(1H-indol-3-yl)-2-[(phenylmethyl)sulfonyl]- Structure](CAS/20200331/GIF/313526-24-8.gif) |
| | Isoquinoline, 1,2-dihydro-1-(1H-indol-3-yl)-2-[(phenylmethyl)sulfonyl]- Chemical Properties |
| Boiling point | 651.2±65.0 °C(Predicted) | | density | 1.38±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : ≥ 150 mg/mL (374.54 mM) | | form | Solid | | pka | 16.67±0.30(Predicted) | | color | Off-white to pink |
| | Isoquinoline, 1,2-dihydro-1-(1H-indol-3-yl)-2-[(phenylmethyl)sulfonyl]- Usage And Synthesis |
| Uses | IBR2 is a potent and specific RAD51 inhibitor and inhibits RAD51-mediated DNA double-strand break repair. IBR2 disrupts RAD51 multimerization, accelerates proteasome-mediated RAD51 protein degradation, inhibits cancer cell growth and induces apoptosis[1][2]. | | References | [1] Jiewen Zhu, et al. A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia. EMBO Mol Med. 2013 Mar;5(3):353-65. DOI:10.1002/emmm.201201760 [2] Zhu J, et al. Synthesis, molecular modeling, and biological evaluation of novel RAD51 inhibitors. Eur J Med Chem. 2015;96:196-208. DOI:10.1016/j.ejmech.2015.04.021 |
| | Isoquinoline, 1,2-dihydro-1-(1H-indol-3-yl)-2-[(phenylmethyl)sulfonyl]- Preparation Products And Raw materials |
|